Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose

American Journal of Veterinary Research

Volumn 67, Issue 10, 2006, Pages 1783-1787

  Kador, Peter F ^a,b   Betts, Daniel ^b,c   Wyman, Milton ^b,d   Blessing, Karen ^a   Randazzo, James ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Therapeutic Vision Inc   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; GALACTITOL; GALACTOSE; INOSITOL; KINOSTAT; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL DISEASE; ANIMAL EUTHANASIA; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DISEASE COURSE; DOG; DRUG MECHANISM; DRUG TISSUE LEVEL; EYE PHOTOGRAPHY; MALE; NONHUMAN; OPTICAL DENSITY; SLIT LAMP;

ADMINISTRATION, TOPICAL; ALDEHYDE REDUCTASE; ANIMAL FEED; ANIMALS; CATARACT; DIET; DOGS; ENZYME INHIBITORS; GALACTOSE; MALE;

ANIMALIA; CANIS FAMILIARIS;

EID: 33750215446     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.10.1783     Document Type: Article

References (32)

1. Feldman EC, Nelson RW. Canine and feline endocrinology and reproduction. Philadelphia: WB Saunders Co, 1996;187-255, 339-394.
2. Guptill L, Glickman L, Glickman N. Time trends and risk factors for diabetes mellitus in dogs: analysis of veterinary medical data base records (1970-1999). Vet J 2003;165:240-247.
3. Kador PF, Kinoshita JH. Diabetic and galactosemic cataracts. Ciba Found Symp 1984;106:110-123.
4. Kinoshita JH, Kador PF, Datiles MD. Aldose reductase in diabetic cataracts. JAMA 1981;246:257-261.
5. Kador PF. Biochemistry of the lens: intermediary metabolism and sugar cataract formation. In: Viola E, Dowling J, eds. Principles and practice of ophthalmology. Volume basic sciences. Philadelphia: WB Saunders Co, 1994;146-167.
6. Datiles M, Fukui H, Kuwabara T, et al. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Invest Ophthalmol Vis Sci 1982;22:174-179.
7. Sakuragawa M, Kuwabara T, Kinoshita JH, et al. Swelling of the lens fibers. Exp Eye Res 1975;21:381-394.
8. Kuwabara T, Kinoshita JH, Cogan DG. Electron microscopic study of galactose-induced cataract. Invest Ophthalmol 1969;8:133-149.
9. Sato S, Takahashi Y, Wyman M, et al. Progression of sugar cataract in the dog. Invest Ophthalmol Vis Sci 1991;32:1925-1931.
10. Monti F, Bellan B, Peruccio C, et al. The clinical picture of diabetic retinopathy in the dog. Folia Vet Lat 1976;6:249-274.
11. Bron AJ, Brown NA, Harding JJ, et al. The lens and cataract in diabetes. Int Ophthalmol Clin 1998;38:37-67.
12. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 1999;13:23-30.
13. Obrosova IG, Fathallah L. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study. Diabetologia 2000;43:1048-1055.
14. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in lens. Proc Natl Acad Sci U S A 1995;92:2780-2784.
15. Salgado D, Reusch C, Spiess B. Diabetic cataracts: different incidence between dogs and cats. Schweiz Arch Tierheilkd 2000; 142:349-353.
16. Richter M, Guscetti F, Spiess B. Aldose reductase activity and glucose-related opacities in incubated lenses from dogs and cats. Am J Vet Res 2002;63:1591-1597.
17. Kador PF, Lee JW, Fujisawa S, et al. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats. J Ocul Pharmacol Ther 2000;16:149-160.
18. Chiou SH, Chylack LT Jr, Bunn HF, et al. Role of nonenzymatic glycosylation in experimental cataract formation. Biochem Biophys Res Commun 1980;95:894-901.
19. Obrosova I, Faller A, Burgan J, et al. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor. Curr Eye Res 1997;16:34-43.
20. Lou MF, Dickerson JE Jr, Garadi R, et al. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res 1988;46:517-530.
21. Datiles MB III, Fukui H. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil. Curr Eye Res 1989; 8:233-237.
22. Sato S, Mori K, Wyman M, et al. Dose-dependent inhibition of sugar cataract formation in galactose-fed dogs by the aldose reductase inhibitor M79175. Exp Eye Res 1998;66:217-222.
23. Beyer-Mears A, Kelly K, Cruz E. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract. Pharmacology 1985;31:170-179.
24. Beyer-Mears A, Cruz E, Varagiannis E. Reversal of stage-I sugar cataract by sorbinil, an aldose reductase inhibitor. Pharmacology 1985;31:88-96.
25. Hu TS, Datiles M, Kinoshita JH. Reversal of galactose cataract with sorbinil in rats. Invest Ophthalmol Vis Sci 1983;24:640-644.
26. Reddy VN, Schwass D, Chakrapani B, et al. Biochemical changes associated with the development and reversal of galactose cataracts. Exp Eye Res 1976;23:483-493.
27. Miwa I, Kanbara M, Wakazono H, et al. Analysis of sorbitol, galactitol, and myo-inositol in lens and sciatic nerve by high-performance liquid chromatography. Ann Biochem 1988; 173:39-44.
28. Wyman M, Sato S, Akagi Y, et al. The dog as a model for ocular manifestations of high concentrations of blood sugars. J Am Vet Med Assoc 1988;193:1153-1156.
29. Lackner PA, Rodriguez L, Sato S, et al. Age-dependent changes in galactose-fed dogs. Exp Eye Res 1997;64:431-436.
30. Hoyle VR, Gilbert PJ, Troke JA, et al. Studies on the biochemical effects of the aldose reductase inhibitor 2,7-difluorospirofluorene-9,5′-imidazolidine-2′,4′- dione (Al 1576, HOE 843). Detection of D-glucaric and D-glucuronic acid excretion by high resolution 1H and 13C NMR spectroscopy. Biochem Pharmacol 1992;44:231-241.
31. Thomas T, Rauscher F, Sanders R, et al. Effects of aldose reductase inhibitors on antioxidant defense in rat and rabbit liver. Toxicol Sci 2000;53:145-149.
32. Sastry SG, Sanders RA, Veltman JC, et al. Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits. Drug Metab Dispos 1995;23:1094-1098.